Vagus nerve stimulation in the treatment of epilepsy: Payment policy perspectives
- PMID: 29473594
- PMCID: PMC5765828
- DOI: 10.1212/CPJ.0b013e3182a3931f
Vagus nerve stimulation in the treatment of epilepsy: Payment policy perspectives
Abstract
This article is presented as a companion to the recent American Academy of Neurology (AAN) guideline update on use of vagus nerve stimulation (VNS) for treating epilepsy. The guideline update reaffirms the efficacy of VNS for intractable epilepsy. Whereas it upholds the value of VNS for its originally approved indications, the guideline reminds us of existing evidence gaps and unmet research needs. This companion identifies ambiguities in the definition of intractable epilepsies and discusses the use of VNS in children under age 12 years and in persons with intellectual disabilities (mental retardation). Many payers require prior authorization and fulfillment of criteria for coverage of VNS. This article provides guidance and background information to reduce obstacles for coverage, especially where uncertainties exist and levels of evidence are lower.
Similar articles
-
Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Payment policy perspectives.Neurol Clin Pract. 2016 Jun;6(3):281-286. doi: 10.1212/CPJ.0000000000000243. Neurol Clin Pract. 2016. PMID: 29443136 Free PMC article.
-
Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial.Trials. 2019 Jan 14;20(1):44. doi: 10.1186/s13063-018-3087-4. Trials. 2019. PMID: 30642370 Free PMC article.
-
The Present and Future of Vagus Nerve Stimulation.J Korean Neurosurg Soc. 2019 May;62(3):344-352. doi: 10.3340/jkns.2019.0037. Epub 2019 May 1. J Korean Neurosurg Soc. 2019. PMID: 31085961 Free PMC article.
-
Vagus nerve stimulation (VNS) therapy update.Epilepsy Behav. 2018 Nov;88S:2-10. doi: 10.1016/j.yebeh.2018.06.032. Epub 2018 Jul 13. Epilepsy Behav. 2018. PMID: 30017839 Review.
-
Vagus nerve stimulation therapy in partial epilepsy: a review.Acta Neurol Belg. 2016 Sep;116(3):241-8. doi: 10.1007/s13760-016-0616-3. Epub 2016 Feb 24. Acta Neurol Belg. 2016. PMID: 26908034 Review.
Cited by
-
Practical considerations in epilepsy neurostimulation.Epilepsia. 2022 Oct;63(10):2445-2460. doi: 10.1111/epi.17329. Epub 2022 Aug 9. Epilepsia. 2022. PMID: 35700144 Free PMC article. Review.
References
-
- Kwan P, Arzimanoglou A, Berg AT. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–1077. - PubMed
-
- Williams LS. Patient-reported outcomes. Neurology. 2012;78:1813–1814. - PubMed
-
- Depositario-Cabacar DF, Zelleke TG. Treatment of epilepsy in children with developmental disabilities. Dev Disabil Res Rev. 2010;16:239–247. - PubMed
-
- Schalock RL, Luckasson RA, Shogren KA. The renaming of mental retardation: understanding the change to the term intellectual disability. Intellect Dev Disabil. 2007;45:116–124. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources